Product Name
AKR1D1, Polyclonal Antibody
Full Product Name
AKR1D1 antibody - middle region
Product Gene Name
anti-AKR1D1 antibody
[Similar Products]
Product Synonym Gene Name
3o5bred; CBAS2; SRD5B1[Similar Products]
Antibody/Peptide Pairs
AKR1D1 peptide (MBS3239890) is used for blocking the activity of AKR1D1 antibody (MBS3214966)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence
Synthetic peptide located within the following region: YVDLYIIEVP MAFKPGDEIY PRDENGKWLY HKSNLCATWE AMEACKDAGL
3D Structure
ModBase 3D Structure for P51857
Species Reactivity
Cow, Dog, Horse, Human, Mouse, Pig, Rabbit, Rat
Purity/Purification
Affinity Purified
Form/Format
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Homology
Cow: 86%; Dog: 93%; Horse: 93%; Human: 100%; Mouse: 92%; Pig: 86%; Rabbit: 100%; Rat: 77%
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human AKR1D1
Preparation and Storage
For short term use, store at 2-8 degree C up to 1 week. For long term storage, store at -20 degree C in small aliquots to prevent freeze-thaw cycles.
Other Notes
Small volumes of anti-AKR1D1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-AKR1D1 antibody
This is a rabbit polyclonal antibody against AKR1D1. It was validated on Western Blot
Target Description: The enzyme encoded by this gene is responsible for the catalysis of the 5-beta-reduction of bile acid intermediates and steroid hormones carrying a delta(4)-3-one structure. Deficiency of this enzyme may contribute to hepatic dysfunction. Three transcript variants encoding different isoforms have been found for this gene. Other variants may be present, but their full-length natures have not been determined yet.
Product Categories/Family for anti-AKR1D1 antibody
Polyclonal; Cancer; Drugs and Drug Metabolism; Disease Related;
Applications Tested/Suitable for anti-AKR1D1 antibody
Western Blot (WB)
Western Blot (WB) of anti-AKR1D1 antibody
WB Suggested Anti-AKR1D1 Antibody
Titration: 1.0 ug/ml
Positive Control: RPMI-8226 Whole Cell

NCBI/Uniprot data below describe general gene information for AKR1D1. It may not necessarily be applicable to this product.
NCBI Accession #
NP_005980
[Other Products]
NCBI GenBank Nucleotide #
NM_005989
[Other Products]
UniProt Primary Accession #
P51857
[Other Products]
UniProt Related Accession #
P51857[Other Products]
NCBI Official Full Name
3-oxo-5-beta-steroid 4-dehydrogenase isoform 1
NCBI Official Synonym Full Names
aldo-keto reductase family 1 member D1
NCBI Official Symbol
AKR1D1 [Similar Products]
NCBI Official Synonym Symbols
CBAS2; SRD5B1; 3o5bred
[Similar Products]
NCBI Protein Information
3-oxo-5-beta-steroid 4-dehydrogenase
UniProt Protein Name
3-oxo-5-beta-steroid 4-dehydrogenase
UniProt Synonym Protein Names
Aldo-keto reductase family 1 member D1; Delta(4)-3-ketosteroid 5-beta-reductase; Delta(4)-3-oxosteroid 5-beta-reductase
Protein Family
3-oxo-5-beta-steroid 4-dehydrogenase
UniProt Gene Name
AKR1D1 [Similar Products]
UniProt Synonym Gene Names
SRD5B1 [Similar Products]
UniProt Entry Name
AK1D1_HUMAN
NCBI Summary for AKR1D1
The enzyme encoded by this gene is responsible for the catalysis of the 5-beta-reduction of bile acid intermediates and steroid hormones carrying a delta(4)-3-one structure. Deficiency of this enzyme may contribute to hepatic dysfunction. Three transcript variants encoding different isoforms have been found for this gene. Other variants may be present, but their full-length natures have not been determined yet. [provided by RefSeq, Jul 2010]
UniProt Comments for AKR1D1
AKR1D1: Efficiently catalyzes the reduction of progesterone, androstenedione, 17-alpha-hydroxyprogesterone and testosterone to 5-beta-reduced metabolites. The bile acid intermediates 7- alpha,12-alpha-dihydroxy-4-cholesten-3-one and 7-alpha-hydroxy-4- cholesten-3-one can also act as substrates. Defects in AKR1D1 are the cause of congenital bile acid synthesis defect type 2 (CBAS2); also known as cholestasis with delta(4)-3-oxosteroid 5-beta-reductase deficiency. Patients with this liver disease show absence or low levels of chenodeoxycholic acid and cholic acid in plasma and urine. Belongs to the aldo/keto reductase family. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: EC 1.3.1.3; Lipid Metabolism - C21-steroid hormone; Lipid Metabolism - androgen and estrogen; Lipid Metabolism - primary bile acid biosynthesis; Oxidoreductase
Chromosomal Location of Human Ortholog: 7q32-q33
Cellular Component: cytosol
Molecular Function: aldo-keto reductase activity; steroid binding
Biological Process: androgen metabolic process; bile acid biosynthetic process; C21-steroid hormone metabolic process; cholesterol catabolic process; digestion
Disease: Bile Acid Synthesis Defect, Congenital, 2
Research Articles on AKR1D1
1. T(p.Q285X), two novel mutations originated from his mother and father, respectively">infant proved to be a compound heterozygote of the AKR1D1 variants c.579+2delT and c.853C>T(p.Q285X), two novel mutations originated from his mother and father, respectively
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.